48th IBS Conference focuses on viral diseases and immunology

FHS
July 11, 2023
11:48 pm

The Institute for Basic Science (IBS) is organizing the IBS-KAI Conference from July 12th to 14th at the Hotel ICC Daejeon.

Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement in insider trading case

A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care activist investor Alex Denner of making nearly $50 million from

April 29, 2024

Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – October 4, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology

October 4, 2024

GSK concludes Aiolos Bio acquisition for up to $1.4bn

Share this article GSK’s respiratory portfolio focuses on therapies for diseases characterised by high eosinophil levels or high T2 inflammation. Credit: nitpicker / Shutterstock.com. GSK

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.